Navigation Links
Nanomedical Diagnostics Issued Key Patent for AGILE R100, a Graphene Biosensor for Drug Discovery
Date:5/9/2017

The United States Patent and Trademark Office has issued U.S. Patent No. 9,618,476 to Nanomedical Diagnostics, a biotech company pioneering label-free graphene biosensors for use in drug discovery. The patent covers any holistic graphene biosensor system that detects biomolecular interactions and is a foundational patent behind the company’s AGILE R100 platform.

“This patent showcases our company commitment to bringing cutting-edge nanotechnology to the life science world,” says Nanomedical Diagnostics founder and CTO, Dr. Brett Goldsmith, also the inventor named on the patent. “Graphene biosensors solve many problems encountered with current sensing tools and enable capabilities that aren’t possible with existing techniques. We are committed to developing graphene biosensors into sensitive measurement tools that help biomedical researchers make confident decisions earlier. The issuance of this patent demonstrates that.”

The patent issue highlights the achievement of the Nanomedical Diagnostics technology team in developing a novel approach for label-free detection of biomolecular interactions. The ability to leverage graphene biosensors in a user-friendly, complete system enables sensitivity, small sample sizes, portability, and ease of use that open new applications in the fields of drug discovery, disease diagnostics, health monitoring, and biomanufacturing.

AGILE R100 is available for commercial sale, for research use only.

Read the full story at http://www.prweb.com/releases/Nanomedical_Diagnostics/Patent_issued/prweb14317265.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. Nanomedical Diagnostics VP Production to Speak at Materials Research Society Spring Meeting
2. Nanomedical Diagnostics Announces Partnership with Rogue Valley Microdevices, Delivering World’s First Successful High-Volume Manufacturing for Graphene Biosensors
3. Nanomedical Diagnostics to Present Field Effect Biosensing for Fragment-Based Drug Discovery at SLAS 2017
4. Nanomedical Diagnostics CEO and CTO to Introduce Electronic Label-Free Assay Based on Field Effect Biosensing Technology at IDTechEx Show
5. Nanomedical Diagnostics launches a new graphene biosensor with unprecedented functionality for small molecule and protein analysis
6. Nanomedical Diagnostics Announces Scientific Advisory Board of Top Scientists and Medical Researchers
7. ClearLight Diagnostics and Researchers at the Indiana Universitys Melvin and Bren Simon Cancer Center Announce a Collaboration to Profile the Tumor Microenvironment in Patients with Breast Cancer
8. Molecular or Immunoassay? Which Technology Will Win the Race for the Point of Care Diagnostics Market?
9. EU Adopts New Diagnostics and Medical Device Regulations, USDM Life Sciences Helps Organizations Comply
10. Personal Genome Diagnostics Announces AACR Annual Meeting 2017 Presentations and Awards
11. Personal Genome Diagnostics Announces Expanded Cancer Testing Contract with U.S. Department of Veteran Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):